Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
(2005) In British Journal of Cancer 93(7). p.834-837- Abstract
- An association between human herpesvirus 8 (HHV8) and multiple myeloma ( MM) has been reported, though most studies have not confirmed such association. To follow-up on a previous prospective seroepidemiological study, where HHV8 tended to associate with MM risk, we linked five large serum banks in the Nordic countries with the Nordic cancer registries and 329 prospectively occurring cases of MM were identified, together with 1631 control subjects matched by age and gender. The HHV8 seroprevalences among cases and controls were similar ( 12 and 15%, respectively) and HHV8 seropositivity did not associate with the risk of MM, neither when considering positivity for lytic antibodies ( relative risk (RR) 0.8, 95% confidence interval (CI) 0.5... (More)
- An association between human herpesvirus 8 (HHV8) and multiple myeloma ( MM) has been reported, though most studies have not confirmed such association. To follow-up on a previous prospective seroepidemiological study, where HHV8 tended to associate with MM risk, we linked five large serum banks in the Nordic countries with the Nordic cancer registries and 329 prospectively occurring cases of MM were identified, together with 1631 control subjects matched by age and gender. The HHV8 seroprevalences among cases and controls were similar ( 12 and 15%, respectively) and HHV8 seropositivity did not associate with the risk of MM, neither when considering positivity for lytic antibodies ( relative risk (RR) 0.8, 95% confidence interval (CI) 0.5 - 1.1) nor for latent antibodies ( RR 0.6, 95% CI 0.1 - 2.7). Similar risks were seen when analysis was restricted to case - control sets with at least 2 years lag before diagnosis ( RR 0.8, 95% CI 0.5 - 1.2 and RR 0.9, 95% CI 0.1 - 4.2). In conclusion, the data indicate that HHV8 infection is not associated with MM. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/223475
- author
- Tedeschi, R ; Luostarinen, T ; De Paoli, P ; Gislefoss, RE ; Tenkanen, L ; Virtamo, J ; Koskela, P ; Hallmans, G ; Lehtinen, M and Dillner, Joakim LU
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- nested, HHV8, multiple myeloma, immunofluorescence, biobank, case-control study
- in
- British Journal of Cancer
- volume
- 93
- issue
- 7
- pages
- 834 - 837
- publisher
- Nature Publishing Group
- external identifiers
-
- wos:000232146100017
- pmid:16136049
- scopus:27144432832
- ISSN
- 1532-1827
- DOI
- 10.1038/sj.bjc.6602751
- language
- English
- LU publication?
- yes
- id
- 7ff95c2b-fd15-42e5-99b9-2417156d4e82 (old id 223475)
- date added to LUP
- 2016-04-01 12:35:11
- date last changed
- 2022-01-27 07:06:18
@article{7ff95c2b-fd15-42e5-99b9-2417156d4e82, abstract = {{An association between human herpesvirus 8 (HHV8) and multiple myeloma ( MM) has been reported, though most studies have not confirmed such association. To follow-up on a previous prospective seroepidemiological study, where HHV8 tended to associate with MM risk, we linked five large serum banks in the Nordic countries with the Nordic cancer registries and 329 prospectively occurring cases of MM were identified, together with 1631 control subjects matched by age and gender. The HHV8 seroprevalences among cases and controls were similar ( 12 and 15%, respectively) and HHV8 seropositivity did not associate with the risk of MM, neither when considering positivity for lytic antibodies ( relative risk (RR) 0.8, 95% confidence interval (CI) 0.5 - 1.1) nor for latent antibodies ( RR 0.6, 95% CI 0.1 - 2.7). Similar risks were seen when analysis was restricted to case - control sets with at least 2 years lag before diagnosis ( RR 0.8, 95% CI 0.5 - 1.2 and RR 0.9, 95% CI 0.1 - 4.2). In conclusion, the data indicate that HHV8 infection is not associated with MM.}}, author = {{Tedeschi, R and Luostarinen, T and De Paoli, P and Gislefoss, RE and Tenkanen, L and Virtamo, J and Koskela, P and Hallmans, G and Lehtinen, M and Dillner, Joakim}}, issn = {{1532-1827}}, keywords = {{nested; HHV8; multiple myeloma; immunofluorescence; biobank; case-control study}}, language = {{eng}}, number = {{7}}, pages = {{834--837}}, publisher = {{Nature Publishing Group}}, series = {{British Journal of Cancer}}, title = {{Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk}}, url = {{http://dx.doi.org/10.1038/sj.bjc.6602751}}, doi = {{10.1038/sj.bjc.6602751}}, volume = {{93}}, year = {{2005}}, }